Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of Y-2 sublingual tablets for acute ischemic stroke
CTR20210233Phase 3Active
- Sponsor
- Yinuoyi Biotech
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of edaravone dexborneol in ischemic stroke, sponsored by Yinuoyi Biotech. Started Jun 2021; status: active.
02
Drugs
edaravone dexborneol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20210233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210233.